Hansard Adam 4
4 · Applied Therapeutics Inc. · Filed Sep 29, 2023
Insider Transaction Report
Form 4
Hansard Adam
Chief Commercial Officer
Transactions
- Sale
Common Stock
2023-09-27$2.70/sh−9,720$26,244→ 382,755 total
Footnotes (1)
- [F1]The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of compensatory Restricted Stock Units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.